Bestvantage Investments is delighted to announce the closure of the seed round in Matri, a ground-changing menstrual pain relief device company. This round was exclusively advised and participated by marquee angels from Bestvantage Investments.
Matri, a groundbreaking medical device poised to revolutionize the treatment of menstrual pain, has recently concluded a successful seed funding round. With participation from prominent investors from Bestvantage, this funding marks a significant milestone for the company and underscores the immense potential of its innovative technology in the healthcare industry.
Matri's pioneering medical device offers a novel approach to alleviating menstrual pain, a common yet often overlooked issue affecting millions of women worldwide. Developed with cutting-edge technology, Matri aims to provide effective relief from menstrual discomfort, enhancing the quality of life for individuals experiencing these symptoms. The seed funding round signals a vote of confidence from investors in Matri's vision and capabilities. By securing vital financial support, the company is well-positioned to further develop and commercialize its groundbreaking technology, bringing much-needed relief to those suffering from menstrual pain.
"We are thrilled to announce the successful closure of our seed funding round, with participation of esteemed investors form Bestvantage" said Roni Mondal (Founder and CEO) of Matri. "This funding not only validates the potential of our innovative medical device but also enables us to advance our mission of improving women's health and well-being" said Rohan Roy (Co-founder and COO) of Matri.
Matri's proprietary technology represents a significant advancement in the treatment of menstrual pain. Unlike traditional methods that often rely on medication or invasive procedures, Matri offers a non-invasive, drug-free solution that targets pain at its source, providing quick and effective relief for users.
"We believe that Matri has the potential to transform the way menstrual pain is treated, offering a safe, non-invasive alternative for individuals seeking relief", commented Raman Sharma, founder & CEO of Bestvantage.
With the successful conclusion of its seed funding round, Matri is poised to embark on the next phase of its journey, advancing its technology, expanding its reach, and ultimately improving the lives of countless individuals worldwide. As the company continues to make strides in the healthcare industry, it is set to redefine the standard of care for menstrual pain management. For more investment opportunities in prominent startups, please visit www.bestvantageinvestments.com or contact us directly at raman@bestvantageinvestments.com.
Comments